Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-06 · accession 0001470831-25-000297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-07 | 2025-11-06 | BBIO | DANIELS RONALD J | Dir | S - Sale+OE | $63.72 | -61.0K | 17.0K | -78% | -$3.89M |
| D | 2025-11-07 | 2025-11-06 | BBIO | DANIELS RONALD J | Dir | M - OptEx | $34.65 | +61.0K | 78.0K | +359% | +$2.11M |
| D | 2025-11-07 | 2025-11-06 | BBIO | DANIELS RONALD J | Dir | M - OptEx | $0.00 | -61.0K | 30.5K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-06 | S | D | 61,031 | $63.72 | 16,991 | D | — | — | (F1) Represents the weighted average sale price of the shares sold from $63.70 to $63.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-11-06 | M | A | 61,031 | $34.65 | 78,022 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-06 | M | D | 61,031 | $0.00 | 30,523 | D | $34.65 · — to 2030-02-11 | 61,031 Common Stock | (F2) The shares subject to this option vested and became exercisable in three annual installments from February 12, 2020 to February 12, 2023. |